Large-scale testing (Phase 3)Study completedNCT01165008What this trial is testingAnakinra in MyositisWho this might be right forPolymyositisDermatomyositisInclusion Body Myositis Karolinska Institutet
Testing effectiveness (Phase 2)WithdrawnNCT07012057What this trial is testingStudy of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile DermatomyositisWho this might be right forMyositisDermatomyositis National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Not applicableStudy completedNCT05027152What this trial is testingMuscle Function and Effects of Repetitive Task Training in Patients With Inflammatory MyopatiesWho this might be right forIdiopathic Inflammatory MyopathyDermatomyositisPolymyositis Federal University of Espirito Santo 2
Large-scale testing (Phase 3)Active Not RecruitingNCT05523167What this trial is testingInvestigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.Who this might be right forActive Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more argenx 265
Early research (Phase 1)Study completedNCT00010335What this trial is testingPilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune DisordersWho this might be right forSystemic SclerosisSystemic Lupus ErythematosusDermatomyositis+2 more Fred Hutchinson Cancer Center 6
Early research (Phase 1)Study completedNCT03817424What this trial is testingEvaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and DermatomyositisWho this might be right forSystemic Lupus ErythematosusCutaneous Lupus ErythematosusSjogren's Syndrome+3 more Amgen 31
Not applicableStudy completedNCT06874712What this trial is testingInterest of LC-OCT for Diagnosing Inflammatory Dermatoses: ODIN (OCT Dermotoses INflammatoires)Who this might be right forInflammatory Skin Disease, Psoriasiform Dermatoses, Eczematiform Dermatoses, Lichenoid Dermatoses, Psoriasis, Eczema, Lichen, Lupus, Dermatomyositis Hospices Civils de Lyon 210
Post-approval studies (Phase 4)UnknownNCT05375435What this trial is testingEfficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive DermatomyositisWho this might be right forDermatomyositis, Adult TypeInterstitial Lung Disease The First Affiliated Hospital with Nanjing Medical University 120
Large-scale testing (Phase 3)Looking for participantsNCT04972760What this trial is testingBaricitinib in Patients With Relapsing or naïve DermatomyositisWho this might be right forDermatomyositis Assistance Publique - Hôpitaux de Paris 62
Testing effectiveness (Phase 2)WithdrawnNCT02980198What this trial is testingStudy of IFN-K in DermatomyositisWho this might be right forDermatomyositis Neovacs
Early research (Phase 1)Looking for participantsNCT03816345What this trial is testingTesting an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOWho this might be right forAutoimmune DiseaseCrohn DiseaseDermatomyositis+11 more National Cancer Institute (NCI) 300
Large-scale testing (Phase 3)Study completedNCT03267277What this trial is testingSodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult DermatomyositisWho this might be right forDermatomyositisIdiopathic Inflammatory Myopathies National Institute of Environmental Health Sciences (NIEHS) 15
Testing effectiveness (Phase 2)Study completedNCT04628936What this trial is testingOpen-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.Who this might be right forPolymyositisDermatomyositis Kezar Life Sciences, Inc. 18
Testing effectiveness (Phase 2)Study completedNCT04033926What this trial is testingKZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or DermatomyositisWho this might be right forPolymyositisDermatomyositis Kezar Life Sciences, Inc. 25
Not applicableActive Not RecruitingNCT01171573What this trial is testingInvestigating Genes in Patients With Polymyositis and DermatomyositisWho this might be right forMyositis Northern Care Alliance NHS Foundation Trust 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06665256What this trial is testingPhase 2 Study of Rapcabtagene Autoleucel in MyositisWho this might be right forIdiopathic Inflammatory Myopathies Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138898What this trial is testingImmunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyWho this might be right forRheumatic Disease NYU Langone Health 80
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06888973What this trial is testingMesenchymal Stem Cells Infusion in Patients With Autoimmune DiseasesWho this might be right forRheumatoid ArthritisSystemic Lupus Erythematosus (SLE)Systemic Sclerosis+3 more National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 200
Large-scale testing (Phase 3)Ended earlyNCT03981744What this trial is testingUstekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care TreatmentsWho this might be right forPolymyositisDermatomyositis Janssen Pharmaceutical K.K. 51
Testing effectiveness (Phase 2)WithdrawnNCT05361109What this trial is testingBaricitinib for Cutaneous DermatomyositisWho this might be right forDermatomyositis University of Washington